ERBB2 and breast carcinoma: The results showed that serum VEGF-A levels were significantly higher in cats with more aggressive mammary carcinoma subtypes, i.e., HER2-positive and TN normal-like, in accordance with previous studies in human breast cancer [19,33,34,35].